Axcella Health Inc AXLA:NASDAQ

RT Quote | NASDAQ | USD
Last | 10/04/22 EDT
1.92quote price arrow down-0.01 (-0.52%)
Volume
159,081
52 week range
1.35 - 4.40
Loading...
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close1.92
  • 52 Week High4.40
  • 52 Week High Date10/26/21
  • 52 Week Low1.35
  • 52 Week Low Date05/13/22

Key Stats

  • Market Cap101.07M
  • Shares Out52.64M
  • 10 Day Average Volume0.56M
  • Dividend-
  • Dividend Yield-
  • Beta1.27
  • YTD % Change-8.13

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close1.92
  • 52 Week High4.40
  • 52 Week High Date10/26/21
  • 52 Week Low1.35
  • 52 Week Low Date05/13/22
  • Market Cap101.07M
  • Shares Out52.64M
  • 10 Day Average Volume0.56M
  • Dividend-
  • Dividend Yield-
  • Beta1.27
  • YTD % Change-8.13

RATIOS/PROFITABILITY

  • EPS (TTM)-1.73
  • P/E (TTM)-1.11
  • Fwd P/E (NTM)-1.30
  • EBITDA (TTM)-70.674M
  • ROE (TTM)-257.38%
  • Revenue (TTM)0.00
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)270.68%

EVENTS

  • Earnings Date11/08/2022(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Axcella Health Inc

 

Profile

MORE
Axcella Health Inc. is a clinical-stage biotechnology company focused on a new approach to treat complex diseases using compositions of endogenous metabolic modulators (EMMs). The Company’s product candidates are comprised of multiple EMMs that are engineered in distinct combinations and ratios with the goal of simultaneously impacting multiple biological pathways. AXA1665 is being developed as a product candidate for the reduction in risk of overt hepatic encephalopathy...
David Epstein
Chairman of the Board
William Hinshaw Jr.
President, Chief Executive Officer, Director
Robert Crane
Chief Financial Officer
Shreeram Aradhye M.D.
Executive Vice President, Chief Medical Officer
Address
840 Memorial Dr
Cambridge, MA
02139-3789
United States

Top Peers

SYMBOLLASTCHG%CHG
CADL
Candel Therapeutics Inc
3.14-0.06-1.88%
MIRO
Miromatrix Medical Inc
4.36-0.03-0.68%
RZLT
Rezolute Inc
2.84+0.10+3.65%
ACHL
Achilles Therapeutics PLC
2.39+0.12+5.29%
ADVM
Adverum Biotechnologies Inc
1.03+0.03+3.00%